From Catching Disease to Getting Ahead of It: The Rise of Proactive Care

BY Dr Andrew Fang, Medical Director, Doctor Anywhere.

Health screening as we know it began as a population-level idea. Mass chest X-rays for tuberculosis, Pap smears for cervical cancer, mammograms, colonoscopies — these programmes were built to catch disease early in large groups of people, using the same test, at the same age, for everyone. It worked. Death rates from cervical and colorectal cancer fell sharply in countries that rolled out routine screening. The logic was simple and powerful: find the problem before it becomes a crisis, and outcomes improve dramatically. For decades, this one-size-fits-all model was the backbone of preventive medicine, and it saved millions of lives.

But population averages only get you so far. Two 45-year-olds can have wildly different risk profiles depending on their genetics, lifestyle, family history, and how their bodies are actually functioning day to day. So the next evolution in screening was personalisation — moving from “everyone gets the same panel at the same age” to tests and intervals tailored to an individual’s actual risk. Someone with a family history of heart disease gets a different cardiac workup than someone without one. Someone with early metabolic warning signs gets followed more closely than someone with none.

Now we’re in the middle of a bigger shift still: from preventive care to proactive care. Preventive care asks, “how do we catch disease early?” Proactive care asks a different question: “where can we optimise, before disease even develops, and how do we slow the changes that come with age?” It’s a move from waiting for a threshold to be crossed, to actively tracking the trajectory a body is on and intervening upstream, well before anything is technically wrong.

A good example of this shift is how we look at metabolic health. For years, the standard was a fasting blood glucose test — a useful but blunt instrument that only flags trouble once blood sugar itself has started drifting out of range. Guidelines are typically written this way by necessity: they wait for a value to cross an established abnormal threshold before recommending action, because that’s the point at which large population studies can confidently say “this is disease.” But by then, the underlying problem, insulin resistance, has often been building quietly for years, with blood sugar itself still sitting in the “normal” range the whole time. Proactive care leans on tests that can measure insulin resistance more directly, rather than waiting for it to eventually show up as abnormal glucose. The thinking behind this is simple: if a result isn’t optimal, that’s already useful information worth acting on, not something to file away until it eventually tips into “abnormal.”

Biological age is another frontier that’s changed what a health check can tell you. Your chronological age is fixed, but your biological age — how old your body’s systems actually behave, based on markers across inflammation, metabolic function, cellular health, and more — is not. It can run older or younger than the number on your birth certificate, and importantly, it can move. Diet, sleep, exercise, stress management, and targeted medical intervention have all been shown to shift biological age markers in a healthier direction over time. That reframes a health screening from a one-off report card into something more like a dashboard you can actually influence.

This is the thinking behind proactive, longevity-focused medicine more broadly: pulling together the population-level rigour that made screening effective in the first place, the personalisation that made it relevant to the individual, and a proactive lens that lets you act on your own trajectory rather than wait for a diagnosis to force your hand. Rather than a single test for a single disease, it’s a wider, ongoing read on the systems that actually determine how well, and how long, you live.

The through-line across all of this is the same one that has defined good medicine for a century: information you can act on, delivered before it’s too late to matter. Proactive care isn’t about chasing novelty for its own sake — it’s about using better tools to answer an old question earlier and more precisely: not just “am I sick,” but “how well am I actually ageing, and what can I do about it now.” That shift, from waiting for disease to actively managing the trajectory, is where the future of health screening is heading.

At DA Orchard MedSuites, our longevity screen looks at seven key indicators of biological ageing – starting with what your body can do physically and mentally, then its structure, its underlying biochemistry, and finally, a single measure of biological age itself. Each one exists because it answers something a standard annual check doesn’t ask: how efficiently your cardiovascular system is really working, what your body composition looks like beneath the number on the scale, how quickly your arteries are ageing, and what’s happening at a cellular level long before it would ever show up as a diagnosis. Book your screen today at DA Orchard MedSuites here.